TruthArchive.ai - Related Video Feed

Kevin McKernan provides a whirlwind tour of DNA contamination in vaccines. He highlights the existence of DNA contamination in vaccines based on various studies and documents. McKernan criticizes the regulators' response, stating that they have turned to the vaccine manufacturers for answers, which he believes are misleading. He also discusses the use of different measurement methods and the potential risks associated with DNA contamination, including the integration of foreign DNA into human cells. McKernan calls for further screening of various biological samples for vaccine residue and encourages CLIA Laboratories to take an interest in this matter.

The Pfizer and Moderna vaccines contain fragments of DNA, which can integrate into the genomic DNA of cells and become a permanent part of the cell. This poses a potential risk of autoimmune attacks and future cancer. The DNA contamination occurred during the production process, where a plasmid vector was used to scale up the production of the RNA template. The regulatory threshold for DNA in vaccines is outdated and not suitable for this new type of vaccine. The speaker believes that DNA sequencing should be done on vaccinated individuals' stem cells to determine if this theoretical risk has occurred. Informed consent is necessary, and the lack of transparency regarding the DNA contamination is concerning.

Thank you, Senator Johnson. I want to address the DNA contamination found in Pfizer and Moderna mRNA vaccines, which has been confirmed by multiple labs and acknowledged by regulatory agencies like the FDA and EMA. They downplay the significance of this contamination, claiming it has no functional consequences, which is misleading. DNA contamination can lead to insertional mutagenesis, as noted in Moderna's patents. The contamination levels vary significantly between lots, and current measurement methods allow for selective reporting. We have evidence that this DNA can integrate into the genome, raising concerns about genotoxicity, especially given the rise in cancer drug sales since the vaccine rollout. Regulatory practices need to be reviewed, particularly the PDUFA Act, which allows regulators to accept funding from the companies they oversee, creating conflicts of interest. Informed consent processes have not addressed this contamination issue, yet mandates persist based on flawed regulatory guidance. Thank you.

Kevin McKernan, a genomics expert, discusses the contamination found in mRNA vaccines. He explains that the vaccines on the market differ from those used in clinical trials, with different levels of contamination. The contamination includes plasmid and bacterial DNA, as well as lipopolysaccharides, which can cause adverse reactions. McKernan reveals that certain functional DNA components were intentionally omitted from the plasmid map submitted to regulators. He emphasizes that the vaccines contain a significant amount of contaminating DNA, which is not easily degraded due to its encapsulation in lipid nanoparticles. McKernan's findings have been replicated by various researchers, highlighting the need for further investigation into the potential risks associated with this contamination.

Many labs, including Medicinal Genomics, found DNA contamination in Pfizer and Moderna mRNA vaccines. Regulators like the FDA and EMA admitted to this, but downplayed its significance. The SP 40 sequences omitted by Pfizer are crucial. DNA contamination can cause insertional mutagenesis, as stated in Moderna's patents. Regulatory agencies were deceived and failed to properly address the issue. This poses a serious risk that cannot be ignored.

The speaker discusses DNA contamination found in Pfizer and Moderna mRNA vaccines, highlighting regulatory agencies' failure to address the issue. They mention potential risks of DNA integration and cancer development, urging for a review of regulatory practices. Concerns are raised about DNA levels exceeding limits, potential cell integration, and long-term presence in the body. The speaker emphasizes the need for better monitoring tools and the unique nature of DNA contamination in these vaccines.

Kevin McKernan, an experienced genomic expert, discusses his findings regarding mRNA vaccines. He discovered that the expression vectors for the vaccines, which are used to produce the spike protein, are still present in the vials. These vectors exceed the guidelines set by the EMA and FDA. McKernan explains the two different processes used in the clinical trials and how residual plasmids from E. coli amplification remain in the vaccines. He specifically highlights the presence of the SV40 promoter in Pfizer vaccines, which was not disclosed to the regulatory agencies. McKernan's team conducted quantitative PCR assays and found high levels of vector DNA in the vials. He emphasizes the importance of understanding the potential risks associated with this contamination and encourages others to replicate his work.

Philip Buchholtz, a cancer genomics researcher, discusses his concerns about the Pfizer vaccine. He explains that the vaccine contains DNA, which has the potential to integrate into cells and cause long-term effects, such as autoimmune reactions and cancer. Buchholtz conducted DNA sequencing on vaccine samples and found that there were millions of copies of DNA in each dose. He suggests that further research should be done to investigate the potential risks. Buchholtz believes that the inclusion of DNA in the vaccine was likely an oversight rather than intentional, but he emphasizes the need for regulatory oversight and proper evaluation of the vaccine's safety.

Philip Buchholz, a biochemistry and molecular biology expert, discusses concerns about the Pfizer vaccine. He explains that the vaccine contains DNA contamination, which could have serious consequences such as autoimmune attacks and potential cancer risks. Buchholz emphasizes that the DNA can integrate into cells and become a permanent fixture, unlike RNA or proteins. He suggests conducting tests on vaccinated individuals to determine if the DNA is integrating into their genomes. Buchholz calls for regulatory oversight to address this issue and remove the DNA from future vaccine versions. He believes the contamination was likely an oversight rather than intentional.

Kevin McKernan, Chief Science Officer and Founder of Medicinal Genomics, discusses his research on DNA plasmids found in Moderna and Pfizer COVID-19 vaccines. The DNA contamination in the vaccines is concerning due to potential long-term effects and the risk of genome integration. McKernan highlights the lack of quality control and transparency in the manufacturing process. He also raises concerns about the potential for prothrombotic effects and the presence of an oncogenic virus promoter in the DNA. McKernan emphasizes the need for further research and replication of his findings to better understand the extent of DNA contamination in the vaccines.

I'm Philippe Boucalt, a cancer genomics researcher at the University of South Carolina. I've sequenced the DNA in the Pfizer vaccine and found that it contains fragments of DNA. This DNA could potentially cause rare but serious side effects, such as cardiac arrest and future cancer risks. The regulatory process that allowed this contamination is concerning. The DNA could integrate into long-lived somatic cells and potentially cause autoimmune attacks or disrupt tumor suppressors. To produce the vaccine, they cloned the PCR product into a plasmid vector, which led to the contamination. We can easily measure the amount of this substance in the vaccine and should conduct further studies to understand its implications. The FDA should require Pfizer to remove the DNA from the vaccine.

In this video, the speakers discuss new information about the mRNA vaccines and the presence of DNA in them. Researchers have found that some mRNA vaccines contain DNA fragments, which can cause issues with gene expression and potentially increase the risk of cancer. The presence of DNA in the vaccines is a manufacturing problem, and it is unclear why it was included. The DNA can enter cells and interfere with important genes, leading to various health problems. The speakers emphasize the need to investigate the extent of DNA contamination in the vaccines and consider stopping their production until the issue is resolved.

The speaker discusses the presence of DNA in the Pfizer vaccine and expresses concern about its potential consequences. They explain that they sequenced the DNA in the vaccine and found it surprising that any DNA was present. The speaker suggests that this DNA could be causing rare but serious side effects, such as death from cardiac arrest. They also mention that the DNA could integrate into the genomic DNA of cells, potentially leading to genome modification and autoimmune attacks. There is a theoretical risk of future cancer as well. The speaker emphasizes the need to investigate these concerns further.

The speaker raises concerns about the contamination of current vaccines with DNA and the unknown consequences of this contamination. They argue that efforts should be made to eliminate DNA contamination, even if it increases production costs. The speaker mentions a researcher from MIT who accidentally discovered that mRNA vaccines were contaminated with DNA. They criticize Pfizer for testing vaccines from one process and then vaccinating billions of people with vaccines from another process, which were contaminated with DNA. The presence of DNA in the vaccines raises risks, including potential cancer development. The speaker believes it is misleading to claim that the vaccines have undergone clinical trials when they have not been properly studied. They call for more rigorous research before commercializing vaccines.

The speaker raises concerns about the contamination of current vaccines with DNA and the unknown consequences of this contamination. They argue that efforts should be made to eliminate DNA contamination, even if it means higher production costs. The speaker mentions a researcher from MIT who discovered that mRNA vaccines were contaminated with DNA, despite DNA not being listed as a component. They criticize the authorities for testing vaccines without DNA contamination on a small group of people, but then vaccinating billions of people with contaminated vaccines. The speaker highlights the potential risks of DNA contamination, including the possibility of cancer. They conclude by stating that vaccines from the second process should undergo more rigorous studies before being commercialized.

The Pfizer vaccine may contain DNA in addition to mRNA, according to a scientist who sequenced the vaccine in his lab. He obtained empty vials from a colleague and found DNA in them. This DNA could potentially cause serious side effects and integrate into the genomic DNA of cells, leading to long-term effects. The scientist is concerned about the regulatory process that allowed this to happen and warns of the risks of genome modification and autoimmune attacks. While the risk of cancer is believed to be rare, it is not zero. Further investigation is needed to determine the extent of these risks.

The speaker discusses the issue of DNA contamination in mRNA COVID-19 vaccines and questions the FDA's handling of the situation. They explain that normally rigorous tests are required for genotoxicity and immunogenesis, but the FDA seemed to ignore these requirements. The speaker also mentions that Moderna's own patent acknowledges the concerns related to DNA and insertional immunogenesis. They reveal that DNA fragments, including an antibiotic resistance gene and sequences from simian virus 40, were found in the vaccines. The speaker expresses concern about the potential risks associated with DNA damage, such as cancer and birth defects. They criticize the FDA for downplaying the issue and emphasize the importance of transparency.

Kevin McKernan discusses his unexpected journey into vaccine research, initially driven by concerns over PCR testing during the COVID pandemic. After receiving vaccine vials, he discovered unexpected DNA sequences, leading to ethical dilemmas about reporting findings. He emphasizes the lack of regulatory oversight and the potential dangers of DNA contamination in vaccines, which could have unknown health implications. He urges for more rigorous testing methods beyond PCR and highlights the persistence of vaccine DNA in human cells long after vaccination. Recent studies show this DNA can remain detectable for weeks, raising concerns about its potential link to cancer. McKernan calls for increased funding and research into these issues, noting resistance to support within current funding structures.

The Pfizer vaccine contains not only mRNA but also plasma DNA from the vector used in its production. I sequenced samples from two batches of the vaccine in Colombia and found this DNA, which raises concerns about potential health risks. This DNA could integrate into the genomic DNA of cells, leading to permanent changes. Such integration poses theoretical risks, including autoimmune responses and cancer, depending on where the DNA inserts itself in the genome. While these risks may be rare, they warrant investigation to understand their implications better.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

Kevin discovered that the vials used for vaccines are contaminated with bacterial DNA. This is concerning because the modified RNA used in these vaccines creates unusual genetic structures that don't occur naturally. Normally, DNA is in a double helix form, but with modified RNA, there are three strands attached to the DNA. The enzyme used to remove DNA, called DNase, cannot digest these triple-stranded genetic constructs, resulting in DNA contamination in the shots. Pfizer and Moderna should have addressed this issue during the manufacturing process by using different enzymes. This shows that assumptions cannot be made when working with new, unnatural products. The DNA used to manufacture the modified RNA was not properly removed, leading to multiple scary aspects of contamination.

The Pfizer vaccine is contaminated with plasma DNA, not just mRNA. This DNA is the DNA vector used as the template for the in vitro transcription reaction. This was discovered by sequencing vials of Pfizer vaccine from Colombia. It's surprising that there's any DNA in there. The speaker is alarmed about the possible consequences of this, including rare but serious side effects like death from cardiac arrest. Mixing DNA with a lipid complex allows it to enter cells and become a permanent fixture. This is a real hazard for genome modification of long-lived somatic cells, like stem cells, and could cause a sustained autoimmune attack. There is also a very real theoretical risk of future cancer in some people. The risk is not zero and it may be high enough that we ought to figure out if this is happening or not.

The Pfizer vaccine contains DNA contamination in addition to mRNA. The DNA comes from the DNA vector used as a template for making the mRNA. Sequencing analysis of the vaccine revealed the presence of DNA, which could potentially cause serious side effects and integrate into the genomic DNA of cells. This poses risks such as autoimmune attacks and potential future cancer. The DNA contamination likely occurred during the production process. It is important to investigate if this DNA has integrated into the genomes of vaccinated individuals. The FDA should require Pfizer to remove the DNA from future versions of the vaccine. The regulatory limit for DNA in vaccines is outdated and not suitable for this type of vaccine. It is necessary to address this oversight and ensure the safety of the vaccine.

The speaker discusses claims about modified RNA (MOD RNA) vaccines and DNA contamination in plasmids. They state that after creating MOD RNA on plasmids, the plasmid DNA remained and much of it could not be destroyed. They reference Kevin MacKurn’s discovery three years ago that vials were full of plasmid DNA, the whole plasmid and parts of it, and note that authorities allegedly minimized the issue, arguing that it doesn’t matter and that vaccines have saved millions of lives. The speaker asserts that the DNA in the vaccine vials was packaged in lipid nanoparticles and that this DNA would enter human cells. They reference colleagues’ publication last year (the INMODEO publication) showing that the DNA in the vaccine vials entered cells in culture and remained stable in cells for days, just as the MOD RNA did. Despite this, they say authorities dismissed the concerns with reassurance that nothing would happen. A pivotal point is attributed to a recent discovery by Kevin MacKinnon, claimed to be three weeks old, about what happens during transcription in the chromosome. The speaker explains that during production, byproducts occur and some mRNA strands do not detach from the DNA where they are formed, resulting in hybrids of DNA and RNA that come off together. The hybrids are described as dangerous, akin to “sparks of a sparkler,” and the speaker emphasizes that RNase H is an enzyme in the cell that takes care of these sparks and extinguishes them immediately. The speaker states that normal physicians don’t know about this, and they had to read up on RNase H after Jessica urged them to. The claimed consequence of failing to extinguish these hybrids is damage to the chromosome, with the metaphor that fires could light up and damage where they occur. The speaker asserts this could lead to “any illness that you see in the textbooks of medicine,” including tumors, neoplastic disease, autoimmune disease, developmental impairment, and death. They warn that the book of life—the genes and chromosomes—could be set on fire if these hybrids are not neutralized. The speaker says they have given interviews weekly, including one with Gary Null, and allege that this information is spreading worldwide. They claim that this situation is akin to attempted murder and exhort physicians globally not to participate, promising that those who do will be charged. They claim this issue is not limited to COVID vaccines but applies to all MOD RNA vaccines, including a flu MOD RNA vaccine now in use, and possibly veterinary vaccines, which they claim will be heavily contaminated with deadly dangerous hybrids. They urge authorities and controlling bodies to act, warning that they will face court if they fail to address the issue.

Kevin McKernan provides a whirlwind tour of DNA contamination in vaccines. He highlights the presence of DNA contamination in vaccines and the lack of proper disclosure by regulatory bodies. McKernan discusses the bait and switch tactics used during clinical trials and the fraudulent practices employed by Pfizer. He also emphasizes the potential risks associated with DNA contamination, including the integration of foreign DNA into human cells. McKernan calls for increased screening of blood banks, sperm banks, and other medical facilities for residual vaccine DNA. He concludes by urging CLIA Laboratories to take an interest in this issue and emphasizes the need for state-level action since the FDA has demonstrated complicity and fraud.